Global burden of asthma among children

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 11, 2014, Pages 1269-1278

  Asher, I ^a   Pearce, N ^b,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MASSEY UNIVERSITY   (New Zealand)

Author keywords

Asthma; Burden; Children

Indexed keywords

ADOLESCENT; ASTHMA; CHILD; COST OF ILLNESS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HEALTH; HEALTH DISPARITY; HUMAN; MORTALITY; PRESCHOOL CHILD; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; GLOBAL HEALTH; HEALTH STATUS DISPARITIES; HUMANS; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS;

EID: 84908700906     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0170     Document Type: Article

References (65)

1. Asher M I, Keil U, Anderson H R, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-491.
2. Ellwood P, Asher M I, Beasley R, Clayton T O, Stewart AW, ISAAC Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC): Phase Three rationale and methods. Int J Tuberc Lung Dis 2005; 9: 10-16.
3. Murray C J, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-2223.
4. Vos T, Flaxman A D, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-2196.
5. National Institutes of Health. International consensus report on diagnosis and treatment of asthma. Bethesda, MD, UDA: National Heart, Lung, and Blood Institute, National Institutes of Health, 1992.
6. Speight A N, Lee D A, Hey E N. Underdiagnosis and undertreatment of asthma in childhood. Br Med J (Clin Res Ed) 1983; 286: 1253-1256.
7. Douwes J, Pearce N. Epidemiology of respiratory allergies and asthma. In: Ahrens W, Pigeot I, eds. Handbook of epidemiology. 2nd ed. New York, NY, USA: Springer Science+Business Media, 2014.
8. Burney P G J, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-960.
9. Pearce N, Beasley R, Burgess C, Crane J. Asthma epidemiology: principles and methods. New York, NY, USA: Oxford University Press, 1998.
10. Toelle B G, Peat J K, Salome C M, Mellis C M, Woolcock A J. Toward a definition of asthma for epidemiology. Am Rev Respir Dis 1992; 146: 633-637.
11. Pattemore P K, Asher M I, Harrison A C, Mitchell E A, Rea H H, Stewart A W. Ethnic differences in prevalence of asthma symptoms and bronchial hyperresponsiveness in New Zealand schoolchildren. Thorax 1989; 44: 168-176.
12. Pearce N, Beasley R, Pekkanen J. Role of bronchial responsiveness testing in asthma prevalence surveys. Thorax 2000; 55: 352-354.
13. Pekkanen J, Pearce N. Defining asthma in epidemiological studies. Eur Respir J 1999; 14: 951-957.
14. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
15. Anderson H R, Gupta R, Kapetanakis V, et al. International correlations between indicators of prevalence, hospital admissions and mortality for asthma in children. Int J Epidemiol 2008; 37: 573-582.
16. Salomon J A, Vos T, Hogan D R, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2129-2143.
17. Murray C, Salomon J, Mathers C, Lopez A. Summary measures of population health: concepts ethics, measurement and applications. Geneva, Switzerland: WHO, 2002.
18. Brand P L P, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32: 1096-1110.
19. Barry D M, Burr M L, Limb E S. Prevalence of asthma among 12 year old children in New Zealand and South Wales: a comparative survey. Thorax 1991; 46: 405-409.
20. Burr ML, Limb E S, Andrae S, Barry DM, Nagel F. Childhood asthma in four countries: a comparative survey. Int J Epidemiol 1994; 23: 341-347.
21. Leung R, Ho P. Asthma, allergy, and atopy in three south-east Asian populations. Thorax 1994; 49: 1205-1210.
22. Ring J, Kramer U, Schafer T, Abeck D, Vieluf D, Behrendt H. Environmental risk factors for respiratory and skin atopy: results from epidemiological studies in former East and West Germany. Int Arch Allergy Immunol 1999; 118: 403-407.
23. Robertson C F, Bishop J, Sennhauser F H, Mallol J. International comparison of asthma prevalence in children: Australia, Switzerland, Chile. Pediatr Pulmonol 1993; 16: 219-226.
24. von Mutius E, Fritzsch C, Weiland S K, Roll G, Magnussen H. Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. BMJ 1992; 305: 1395-1399.
25. Weiland S K, von Mutius E, Hirsch T, et al. Prevalence of respiratory and atopic disorders among children in the East and West of Germany five years after unification. Eur Respir J 1999; 14: 862-870.
26. Asher M I, Pattemore P K, Harrison A C, et al. International comparison of the prevalence of asthma symptoms and bronchial hyperresponsiveness. Am Rev Respir Dis 1988; 138: 524-529.
27. Weiland S K, Bjorksten B, Brunekreef B, et al. Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J 2004; 24: 406-412.
28. Enarson D A. Fostering a spirit of critical thinking: the ISAAC story. Int J Tuberc Lung Dis 2005; 9: 1.
29. Asher M I, Anderson H R, Stewart A W, et al. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12: 315-335.
30. Lai C K W, Beasley R, Crane J, et al. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009; 64: 476-483.
31. Asher I, Twiss J, Ellwood E. Epidemiology of asthma. In: Bush A, Wilmott R, Chernick V, Boat T, Deterding R, Ratjen F, eds. Kendig & Chernick's disorders of the respiratory tract in children. 8th ed. Philadelphia, PA, USA: Saunders, 2012.
32. Pearce N, Aït-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62: 758-766.
33. Asher M I, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743.
34. World Health Organization. Global tuberculosis report 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013.
35. Ruuskanen O, Lahti E, Jennings L C, Murdoch D R. Viral pneumonia. Lancet 2011; 377: 1264-1275.
36. Pearce N, Asher I, Billo N, et al. Asthma in the global NCD agenda: a neglected epidemic. Lancet Respir Med 2013; 1: 96-98.
37. Phelan P D, Robertson C F, Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol 2002; 109: 189-194.
38. Tai A, Tran H, Roberts M, et al. Outcomes of childhood asthma to the age of 50 years. J Allergy Clin Immunol 2014; 133: 1572-1578.
39. Tai A S N, Tran H, Roberts N, Wilson J, Robertson C F. The association between childhood asthma and chronic obstructive pulmonary disease. Thorax 2014; 69: 805-810.
40. Bahadori K, Doyle-Waters M M, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 9: 24.
41. Strachan D, Pearce N. Factors affecting asthma. In: The International Union Against Tuberculosis and Lung Disease, The International Study of Asthma and Allergies in Childhood, eds. The Global Asthma Report, 2011. Paris, France, 2011.
42. Genuneit J, Cantelmo J L, Weinmayr G, et al. A multi-centre study of candidate genes for wheeze and allergy: the International Study of Asthma and Allergies in Childhood Phase 2. Clin Exp Allergy 2009; 39: 1875-1888.
43. Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999; 54: 268-272.
44. Weinmayr G, Weiland S, Björkstén B, et al. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med 2007; 176: 565-574.
45. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002; 57: 643-648.
46. Douwes J, Pearce N. Asthma and the westernization 'package'. Int J Epidemiol 2002; 31: 1098-1102.
47. von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nature Reviews Immunology 2010; 10: 861-868.
48. Anderson H R, Ruggles R, Pandey K D, et al. Ambient particulate pollution and the worldwide prevalence of asthma, rhinoconjunctivitis and eczema in children: Phase One of the International Study of Asthma and Allergies in Childhood (ISAAC). Occup Environ Med 2010; 67: 293-300.
49. Anderson H R, Butland B K, van Donkelaar A, et al. Satellitebased estimates of ambient air pollution and global variations in childhood asthma prevalence. Environ Health Perspect 2012; 120: 1333-1339.
50. Brunekreef B, Stewart AW, Anderson H R, Lai C K, Strachan D P, Pearce N; ISAAC Phase 3 Study Group. Truck traffic exposure and symptoms of asthma and allergic disease: a global relationship in ISAAC Phase Three. Environ Health Perspect 2009; 117: 1791-1798.
51. Mitchell E A, Beasley R, Keil U, Montefort S, Odhiambo J; ISAAC Phase Three Study Group. The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from Phase Three of the ISAAC programme. Thorax 2012; 67: 941-U128.
52. Wong G W, Brunekreef B, Ellwood P, et al. Cooking fuels and prevalence of asthma: a global analysis of phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Lancet Respir Med 2013; 1: 358.
53. Weinmayr G, Gehring U, Genuneit J, et al. Dampness and moulds in relation to respiratory and allergic symptoms in children: results from Phase Two of the International Study of Asthma and Allergies in Childhood (ISAAC Phase Two). Clin Exp Allergy 2013; 43: 762-774.
54. Beasley R, Clayton T, Crane J, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372: 1039-1048.
55. Beasley RW, Clayton T O, Crane J, et al. Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents International Study of Asthma and Allergies in Childhood Phase Three. Am J Respir Crit Care Med 2011; 183: 171-178.
56. Foliaki S, Pearce N, Bjorksten B, et al. Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies in Childhood Phase III. J Allergy Clin Immun 2009; 124: 982-989.
57. Ellwood P, Asher M I, Garcia-Marcos L, et al. Do fast foods cause asthma, rhinoconjunctivitis and eczema? Global findings from the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Thorax 2013; 68: 351-360.
58. Nagel G, Weinmayr G, Kleiner A, Garcia-Marcos L, Strachan D P, Grp IPTS. Effect of diet on asthma and allergic sensitisation in the International Study on Allergies and Asthma in Childhood (ISAAC) Phase Two. Thorax 2010; 65: 516-522.
59. Mitchell E A, Beasley R, Bjorksten B, et al. The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy 2013; 43: 73-84.
60. Nagel G, Buchele G, Weinmayr G, et al. Effect of breastfeeding on asthma, lung function and bronchial hyperreactivity in ISAAC Phase II. Eur Respir J 2009; 33: 993-1002.
61. Babar Z U, Lessing C, Mace C, Bissell K. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. Pharmacoeconomics 2013; 31: 1063-1082.
62. Aït-Khaled N, Auregan G, Bencharif N, et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tuberc Lung Dis 2000; 4: 268-271.
63. Sembajwe G, Cifuentes M, Tak SW, Kriebel D, Gore R, Punnett L. National income, self-reported wheezing and asthma diagnosis from the World Health Survey. Eur Respir J 2010; 35: 279-286.
64. Chan M. From new estimates to better data. Lancet 2012; 380: 2054.
65. Horton R. GBD 2010: understanding disease, injury, and risk. Lancet 2012; 380: 2053-2054.